Takeda gets FDA approval in Metastatic colorectal cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fruquintinib-refractory-metastatic-colorectal-cancer#:~:text=On%20November%208%2C%202023%2C%20the,if%20RAS%20wild%2Dtype%20and
This was one of things I was watching for in Colorectal cancer in November. Competition here could spawn some interest in Pelareorep in this indication.
Pelareorep is developing a portfolio of gastric indications in Cancer With Pancreatic, Colorectal and now intresting results in Anal cancer.
The GOBLET study was extremely well designed having met it's criteria in 3/3 indications early on.
Cheers!!!!!!!!!!!!!!!!!!!